Advertisement
The Annual meeting is a great way for nurses to see how the innovativePadLock device is designed to promote best practice for aseptic IVadministration set disconnections, preventing touch contamination and securingthe IV line in between drug administrations. They will also be able to seehow the Set Saver can eliminate the use of IV administration set caps, whichare a known choking hazard. The PadLock Set Saver provides temporary asepticstorage of the IV administration line when disconnected from the patient,replacing the need for disposable caps to maintain aseptic procedure.
Advertisement
Baxa Corporation is a world leader in developing innovative technology forthe safe handling, packaging and administration of fluid medications inhospital and alternate-care settings. Renowned for enhancing patient safetyand improving processes within pharmacy settings. With the PadLock Set Saver,Baxa brings its expertise and experience to the patient bedside. Furtherinformation is available at http://www.baxa.com/padlock.
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative,solution-based technologies for medication handling and delivery. Its systemsand devices promote the safe and efficient preparation, handling, packaging,and administration of medications. Key products include the PadLock(R) SetSaver, Rapid-Fill(TM) Automated Syringe Fillers, Exacta-Med(R) OralDispensers, MicroFuse(R) Syringe Infusers, Repeater(TM) Pharmacy Pumps, andExacta-Mix(TM) and MicroMacro(TM) Multi-Source Automated Compounders; usedworldwide in hospitals and healthcare facilities. Privately held, BaxaCorporation has subsidiaries and sales offices in Canada and the UnitedKingdom; direct representation in Austria, Belgium, Finland, France, Germany,Luxembourg, The Netherlands and Switzerland; and distribution partnersworldwide. Further information is available at http://www.baxa.com.Contact: Marian Robinson, Vice President, Marketing Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157 Email: [email protected] Maggie Chamberlin Holben, APR Absolutely Public Relations: 303.984.9801 or 303.669.3558 Email: [email protected]
SOURCE Baxa Corporation
